References: Step 1 Trial: Wilding, J.P.H., et al
Furthermore, GLP-1 RAs not only improve glycaemia but also provide additional benefits such as body weight reduction and protective effects against cardiovascular disease and diabetic kidney disease (DKD), and metabolic dysfunction-associated steatotic liver disease (MASLD)[5,6,7]
Not just a few exceptional responders pulling up the average, but broad, reliable weight loss across the study population
Losing 5% to 10% of body weight has been associated with a reduced risk of cardiovascular disease
1 2 3 "Pernicious Anemia, Clinical Presentation"
Some patients experience gastrointestinal discomfort, but strategies like microdosing or supplementing with digestive enzymes can mitigate these issues, she explains